Anamorelin in Japanese patients with cancer cachexia: an update
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Purpose of review: Anamorelin was approved for production and marketing in Japan on 22 January 2021 for cancer cachexia in non-small-cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer. The authors describe the updates of anamorelin for cancer cachexia in Japan. Recent findings: Recent evidence showed that anamorelin improved lean body mass, body weight, and appetite in patients with cancer cachexia in clinical practice. Anamorelin does not increase body weight in the severe-weight-loss group in cachectic patients with pancreatic cancer. Several case reports showed that anamorelin can cause cardiac adverse drug reactions. Among the cardiac adverse reactions, fatal arrhythmias should be monitored carefully even if it is the first dose. Anamorelin combined with nutrition, physical activity, and exercise may be more useful than anamorelin alone for treating cancer cachexia. An interim analysis from post-marketing all-case surveillance was performed; however, details have not yet been published. When anamorelin cannot be used for cancer cachexia, Kampo medicines can be considered as an option. Summary: Anamorelin has changed the clinical practice of cancer cachexia in Japan. The authors hope that anamorelin is available for other disease-related cachexia along with appropriate multidisciplinary interventions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This oral ghrelin analogue has mostly been studied in cancer217–219 and has anti-inflammatory and anabolic properties.”
From Sarcopenic obesity in older adults: a clinical overview (2024) · cites this paper as [219]
Citations
Cites
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479
Wakabayashi, H., Arai, H., & Inui, A. (2021) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12675 · Cited by 161
Self-citationRespiratory sarcopenia: A position paper by four professional organizations
Satô, S., Miyazaki, S., Tamaki, A., Yoshimura, Y., Arai, H., Fujiwara, D., Katsura, H., Kawagoshi, A., Kozu, R., Maeda, K., et al. (2022) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14519 · Cited by 134
Self-citationRehabilitation Nutrition and Exercise Therapy for Sarcopenia
Kakehi, S., Wakabayashi, H., Inuma, H., Inose, T., Shioya, M., Aoyama, Y., Hara, T., Uchimura, K., Tomita, K., Okamoto, M., et al. (2022) · The World Journal of Men's Health · doi:10.5534/wjmh.200190 · Cited by 108
Self-citationNishioka, S., Aragane, H., Suzuki, N., Yoshimura, Y., Fujiwara, D., Mori, T., Kanehisa, Y., Iida, Y., Higashi, K., Yoshimura, Y., et al. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.02.018 · Cited by 80
Self-citationKose, E., Wakabayashi, H., & Yasuno, N. (2021) · Nutrients · doi:10.3390/nu13061961 · Cited by 67
Self-citationBaracos, V. E., Coats, A. J. S., Anker, S. D., Sherman, L., Klompenhouwer, T., & International Advisory Board, A. R. A. B. F. N. A. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13105 · Cited by 59
Inoue, T., Iida, Y., Takahashi, K., Shirado, K., Nagano, F., Miyazaki, S., Takeuchi, I., Yoshimura, Y., Momosaki, R., Maeda, K., et al. (2022) · JMA Journal · doi:10.31662/jmaj.2021-0201 · Cited by 46
Self-citationNaito, T., Uchino, J., Kojima, T., Matano, Y., Minato, K., Tanaka, K., Mizukami, T., Atagi, S., Higashiguchi, T., Muro, K., et al. (2022) · Cancer · doi:10.1002/cncr.34154 · Cited by 45
Kampo medicines for supportive care of patients with cancer: A brief review
Motoo, Y., & Cameron, S. (2022) · Integrative Medicine Research · doi:10.1016/j.imr.2022.100839 · Cited by 40
Research works printed but not linked: 2
- Takayama, Real-world safety and effectiveness of anamorelin in patients with cancer cachexia in Japan: an interim analysis from post-marketing all-case surveillance (O077-1), The Japan Society of Clinical Oncology
- Takayama, Real-world outcomes of anamorelin in patients with non-small cell lung cancer in Japan (O58-1), The Japan Lung Cancer Society Online Journal
Cited by
Sarcopenic obesity in older adults: a clinical overview
Prado, C. M., Batsis, J. A., Donini, L. M., Gonzalez, M. C., & Siervo, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00943-z · Cited by 355
“This oral ghrelin analogue has mostly been studied in cancer 217–219 and has anti-inflammatory and anabolic properties.”
Pryce, B. R., Oles, A. R., Talbert, E. E., Romeo, M. J., Vaena, S. G., Sharma, S. M., Spadafora, V. K., Tolliver, L. B., Mahvi, D. A., Morgan, K. A., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114925 · Cited by 68
Definition, diagnosis, and treatment of respiratory sarcopenia
Miyazaki, S., Tamaki, A., Wakabayashi, H., & Arai, H. (2023) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000001003 · Cited by 37
Self-citationRubinić, I., Kurtov, M., & Likić, R. (2024) · Pharmacology Research & Perspectives · doi:10.1002/prp2.1243 · Cited by 27
Beyond Hunger: The Structure, Signaling, and Systemic Roles of Ghrelin
Polishchuk, H., Guzik, K., & Kantyka, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210996 · Cited by 20
Metadata
- Authors
- Wakabayashi, H., Arai, H., & Inui, A.
- Affiliations
- Tokyo Women's Medical University Hospital (JP)
- National Center for Geriatrics and Gerontology (JP)
- Kagoshima University (JP)
- Corresponding author
- Wakabayashi, Hidetaka
- Venue
- Current Opinion in Supportive & Palliative Care
- Published
- 2023-06-30
- Volume
- 17
- Issue
- 3
- Pages
- 162-167
- ISSN
- 1751-4258 (ISSN-L)
- OpenAlex
- W4382630874
- Cited by
- 17
- References
- 28
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 8 · 2023: 1
- FWCI
- 0.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Supportive and Palliative Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- anamorelin, cancer cachexia, Japanese patients, non-small cell lung cancer, gastric cancer, pancreatic cancer, colorectal cancer, lean body mass, body weight, appetite, cardiac arrhythmias, Kampo medicine, multidisciplinary intervention, post-marketing surveillance
- MeSH terms
- East Asian People, Body Weight, Cachexia, Carcinoma, Non-Small-Cell Lung, Humans, Hydrazines, Lung Neoplasms, Neoplasms, Oligopeptides, Pancreatic Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anamorelin in Japanese patients with cancer cachexia: an update. https://app.cochat.ai/papers/10.1097/spc.0000000000000658
- The paper
- Wakabayashi, H., Arai, H., & Inui, A. (2023). Anamorelin in Japanese patients with cancer cachexia: an update. Current Opinion in Supportive & Palliative Care. https://doi.org/10.1097/spc.0000000000000658
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.